Aprilm Jorge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study identifies factors associated with hydroxychloroquine retinopathy

Study identifies factors associated with hydroxychloroquine retinopathy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesAprilm jorgeMassachusetts general hospitalRisk factorsHydroxychloroquine retinopathyIts subtypes

Study Identifies Factors Associated With Hydroxychloroquine Retinopathy

Study Identifies Factors Associated With Hydroxychloroquine Retinopathy
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.

United statesAprilm jorgeBristol myers squibbHealthday newsMassachusetts general hospitalHispanic whites

Retinopathy With Long-Term HCQ Use: Large Study IDs Risk Factors

Retinopathy With Long-Term HCQ Use: Large Study IDs Risk Factors
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

United statesAprilm jorgeJohn geverKaiser permanenteHarvard medical schoolMassachusetts general hospitalNorthern californiaManaging editor

Advancing Lupus Care: The Changing Landscape of Treatment

The progression toward more targeted, disease-modifying options for the historically difficult rheumatic disease made more headway in 2023.

United statesAprilm jorgeBrad rovinJack arnoldRosalind ramsey goldmanChris wincupEuropean alliance of associationsOhio state university wexner medical centerDrug administrationKing college hospital lupus unitLeeds centre of rheumaticCollege hospital lupus unitResearch professorNorthwestern university feinberg schoolLeeds centreMassachusetts general hospital

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.

United statesAprilm jorgeEmily hendersonNational institute of arthritisAmerican college of rheumatologyAmerican collegeMassachusetts general hospitalChronic kidney diseaseKidney diseaseRheumatoid arthritisVision loss